ArticleFrontiers in neurology2024

IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model.

Shota Miyake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.